VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John W. Andrews who wrote (11029)	7/9/1998 8:08:00 PM
From: Nick Prezioso	Read Replies (5) of 23519

It is truly amazing that anyone can be long this stock. I can't think of ANY positives for the future of Vivus. Let's see: - Viagra is kicking the hell out of revenues, its potential is enormous $400mil sales in one quarter alone. - Vasomax is right around the corner. - Harvard Scientific is close to developing a topical solution which will be non-invasive. - Inventory levels are extremely high, with demand drying up and a limited shelf life, I expect significant write-offs to be taken next quarter. - oh yeah, forgot to mention that their product does not work. As for a buyout, what would Vivus have to offer a large pharma company? The return on investment would have to be high enough to have an impact on their p/e. Even if Vivus could double their current quarterly revenue it would be immaterial to a company like JNJ or Merk. Just my thoughts. Nick

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next